SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing. (2016)

First Author: Mavrou A

Attributed to: Regulation of VEGF splicing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.phrs.2016.03.013

PubMed Identifier: 26995304

Publication URI: http://europepmc.org/abstract/MED/26995304

Type: Journal Article/Review

Volume: 107

Parent Publication: Pharmacological research

ISSN: 1043-6618